The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, 221000, China
NCT Number: NCT03161977
This is an observational study designed to research the effect of mannitol on the concentration of intraoperative serum potassium in patients undergoing craniotomy, and to guide the safe use of mannitol during craniotomy.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Xuzhou, Jiangsu, 221000, China
Patients were assigned to receive 20% mannitol (1g/kg) solution administered intravenously 15-20 minutes at the time of drilling skull.The serum potassium was measured by arterial blood gas analysis before infusion (T0), infusion finished (T1), 15min (T2), 30min (T3), 60min (T4) and 120min (T5) after infusion.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Mannitol was intravenous infused within 15-20 mins when drilling skull
Time frame: two hours within infusioning mannitol
measured by arterial blood gas analysis
The Affiliated Hospital of Xuzhou Medical University
Other
The Effect of Mannitol on Intraoperative Serum Potassium in Patients Undergoing Craniotomy:an Observational Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04251689
Cis-Platinum Nephropathy, Mannitol Adverse Reaction
Bangkok, Thailand
View Trial DetailsNCT06884657
Mannitol Adverse Reaction
Çukurova, Adana, Turkey (Türkiye)
View Trial DetailsNCT04012138
Glucose Metabolism Disorders, Hyperinsulinism
Agen, France
View Trial DetailsNCT05004363
ACE Inhibitor Induced Hyperkalaemia, Acute Kidney Injury
London, United Kingdom
View Trial Details